The Transcription Factor IRF8 Counteracts BCR-ABL to Rescue Dendritic Cell Development in Chronic Myelogenous LeukemiaTomoya Watanabe(Yokohama City University Medical Center), Tomohiko Tamura(Yokohama City University Medical Center)Cancer ResearchNovember 14, 201310.1158/0008-5472.can-13-0802Cited by 15SaveCiteExport RISWatch citationsRelated PapersIRF8 inhibits C/EBPα activity to restrain mononuclear phagocyte progenitors from differentiating into neutrophils|Nature Communications|2014|145Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation|Cell Reports|2024|8